Literature DB >> 22930296

Bacterial vaginosis is conducive to the persistence of HPV infection.

Y-L Guo1, K You, J Qiao, Y-m Zhao, L Geng.   

Abstract

We investigated the effects of bacterial vaginosis (BV) on the outcomes of high-risk human papillomavirus infection (HR-HPV). BV was diagnosed on Papanicolaou-stained cytology slides of 707 HPV-positive patients. HR-HPV DNA expression was analysed using the Hybrid Capture II (HC-II) assay. Of the 707 HR-HPV-positive female patients, 298 (42.1%) exhibited clearance of HR-HPV. The remaining 409 patients had persistent HR-HPV infection. The persistent HR-HPV group and the clearing group had similar rates of BV at the beginning of the study. At the end of the study, the persistent HR-HPV group had a BV prevalence of 11.2% while the clearing group had a significant lower BV prevalence of 5.0%. A decreased clearance of HPV was found in women with current BV, compared with women without BV. Furthermore, the natural history of HPV was not affected by the HPV viral load or the BV prevalence at the beginning of the study (P > 0.05). Bacterial vaginosis appears conducive to the persistence of HPV infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22930296     DOI: 10.1258/ijsa.2012.011342

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  42 in total

Review 1.  The microbiome and gynaecological cancer development, prevention and therapy.

Authors:  Paweł Łaniewski; Zehra Esra Ilhan; Melissa M Herbst-Kralovetz
Journal:  Nat Rev Urol       Date:  2020-02-18       Impact factor: 14.432

2.  The Role of Chlamydia trachomatis in High-Risk Human Papillomavirus Persistence Among Female Sex Workers in Nairobi, Kenya.

Authors:  Nadja Vielot; Michael G Hudgens; Nelly Mugo; Michael Chitwa; Joshua Kimani; Jennifer Smith
Journal:  Sex Transm Dis       Date:  2015-06       Impact factor: 2.830

Review 3.  Does the vaginal microbiota play a role in the development of cervical cancer?

Authors:  Maria Kyrgiou; Anita Mitra; Anna-Barbara Moscicki
Journal:  Transl Res       Date:  2016-07-15       Impact factor: 7.012

Review 4.  Role of the microbiome in non-gastrointestinal cancers.

Authors:  Meirav Pevsner-Fischer; Timur Tuganbaev; Mariska Meijer; Sheng-Hong Zhang; Zhi-Rong Zeng; Min-Hu Chen; Eran Elinav
Journal:  World J Clin Oncol       Date:  2016-04-10

5.  Association of asymptomatic bacterial vaginosis with persistence of female genital human papillomavirus infection.

Authors:  K Kero; J Rautava; K Syrjänen; S Grenman; S Syrjänen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-07-05       Impact factor: 3.267

6.  Inhibitory Effect of Vaginal Lactobacillus Supernatants on Cervical Cancer Cells.

Authors:  Ke-Di Wang; Dong-Jiang Xu; Bao-Ya Wang; Dong-Hui Yan; Zhi Lv; Jian-Rong Su
Journal:  Probiotics Antimicrob Proteins       Date:  2018-06       Impact factor: 4.609

7.  Interplay between the temporal dynamics of the vaginal microbiota and human papillomavirus detection.

Authors:  Rebecca M Brotman; Michelle D Shardell; Pawel Gajer; J Kathleen Tracy; Jonathan M Zenilman; Jacques Ravel; Patti E Gravitt
Journal:  J Infect Dis       Date:  2014-06-18       Impact factor: 5.226

Review 8.  Viral Infections, the Microbiome, and Probiotics.

Authors:  Ashton Harper; Vineetha Vijayakumar; Arthur C Ouwehand; Jessica Ter Haar; David Obis; Jordi Espadaler; Sylvie Binda; Shrilakshmi Desiraju; Richard Day
Journal:  Front Cell Infect Microbiol       Date:  2021-02-12       Impact factor: 6.073

Review 9.  The Microbiome and Gynecologic Cancer: Current Evidence and Future Opportunities.

Authors:  Laura M Chambers; Parker Bussies; Roberto Vargas; Emily Esakov; Surabhi Tewari; Ofer Reizes; Chad Michener
Journal:  Curr Oncol Rep       Date:  2021-06-14       Impact factor: 5.075

10.  Characteristics and Related Factors of High-Risk Human Papillomavirus Infection in Pregnant Women.

Authors:  Yingying Chen; Jie Dong; Boliang Chu; Xiaoxing Zhang; Xiaofang Ru; Yun Chen; Yunyan Chen; Xiaodong Cheng
Journal:  Med Sci Monit       Date:  2021-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.